Cargando…
Evaluation of accuracy, exclusivity, limit-of-detection and ease-of-use of LumiraDx™: An antigen-detecting point-of-care device for SARS-CoV-2
PURPOSE: Rapid antigen-detecting tests (Ag-RDTs) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can transform pandemic control. Thus far, sensitivity (≤ 85%) of lateral-flow assays has limited scale-up. Conceivably, microfluidic immunofluorescence Ag-RDTs could increase sensitivity...
Autores principales: | Krüger, Lisa J., Klein, Julian A. F., Tobian, Frank, Gaeddert, Mary, Lainati, Federica, Klemm, Sarah, Schnitzler, Paul, Bartenschlager, Ralf, Cerikan, Berati, Neufeldt, Christopher J., Nikolai, Olga, Lindner, Andreas K., Mockenhaupt, Frank P., Seybold, Joachim, Jones, Terry C., Corman, Victor M., Pollock, Nira R., Knorr, Britta, Welker, Andreas, de Vos, Margaretha, Sacks, Jilian A., Denkinger, Claudia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358901/ https://www.ncbi.nlm.nih.gov/pubmed/34383260 http://dx.doi.org/10.1007/s15010-021-01681-y |
Ejemplares similares
-
Performance Evaluation of the Quantitative Point-of-Care LumiraDx d-Dimer Test
por: Ellis, Jayne E., et al.
Publicado: (2021) -
Utilidad del test de antígenos SARS-COV-2 de LumiraDx™ en centros residenciales
por: Domínguez Fernández, Mercedes, et al.
Publicado: (2022) -
The Abbott PanBio WHO emergency use listed, rapid, antigen-detecting point-of-care diagnostic test for SARS-CoV-2—Evaluation of the accuracy and ease-of-use
por: Krüger, Lisa J., et al.
Publicado: (2021) -
Urgent care study of the LumiraDx SARS-CoV-2 Ag Test for rapid diagnosis of COVID-19
por: Gresh, Jared, et al.
Publicado: (2021) -
Performance of the LumiraDx Platform INR Test in an Anticoagulation Clinic
Point-of-Care Setting Compared With an Established Laboratory Reference
Method
por: Tait, Robert Campbell, et al.
Publicado: (2019)